Cargando…

Effect of PTEN loss on metabolic reprogramming in prostate cancer cells

The tumor suppressor gene PTEN is one of the most often deleted genes in human prostate cancer. Loss of PTEN is an important event in prostate carcinogenesis. Metabolic reprogramming induced by PTEN loss fuels malignant growth and proliferation of prostate cancer cells. Targeted metabolomics analysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xin, Yang, Xu, Sun, Xiang, Xu, Xinyuan, Li, Xi'an, Guo, Yan, Wang, Jiancai, Li, Xia, Yao, Libo, Wang, He, Shen, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386093/ https://www.ncbi.nlm.nih.gov/pubmed/30854061 http://dx.doi.org/10.3892/ol.2019.9932

Ejemplares similares

Combined Aberrant Expression of NDRG2 and LDHA Predicts Hepatocellular Carcinoma Prognosis and Mediates the Anti-tumor Effect of Gemcitabine
por: Guo, Yan, et al.
Publicado: (2019)

ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss
por: Chen, Yu, et al.
Publicado: (2013)

Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma
por: Zhao, Chuanzong, et al.
Publicado: (2020)

Correction to: Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma
por: Zhao, Chuanzong, et al.
Publicado: (2021)

Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
por: Xu, Huan, et al.
Publicado: (2021)

Transcriptional landscape of PTEN loss in primary prostate cancer
por: Imada, Eddie Luidy, et al.
Publicado: (2021)

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
por: Lotan, Tamara L., et al.
Publicado: (2017)

Metabolic reprogramming in prostate cancer
por: Ahmad, Fahim, et al.
Publicado: (2021)

Atg7 cooperates with Pten loss to drive prostate cancer tumor growth
por: Santanam, Urmila, et al.
Publicado: (2016)

BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN
por: Deng, Rong, et al.
Publicado: (2020)

Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
por: Chen, Jing, et al.
Publicado: (2018)

PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
por: Punnoose, Elizabeth A, et al.
Publicado: (2015)

Metabolic reprogramming in macrophage responses
por: Liu, Yang, et al.
Publicado: (2021)

NFATc1 Promotes Prostate Tumorigenesis and Overcomes PTEN Loss-Induced Senescence
por: Manda, Kalyan R., et al.
Publicado: (2015)

Is PTEN loss associated with clinical outcome measures in human prostate cancer?
por: McCall, P, et al.
Publicado: (2008)

PTEN loss promotes Warburg effect and prostate cancer cell growth by inducing FBP1 degradation
por: Song, Changze, et al.
Publicado: (2022)

Loss of ATF3 Promotes Akt Activation and Prostate Cancer Development in a Pten Knockout Mouse Model
por: Wang, Ziyan, et al.
Publicado: (2014)

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

PTEN Loss is Associated with Upgrading of Prostate Cancer from Biopsy to Radical Prostatectomy
por: Lotan, Tamara L., et al.
Publicado: (2014)

Prevalence of ERG expression and PTEN loss in a Brazilian prostate cancer cohort
por: Morais, C.E., et al.
Publicado: (2019)

Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis
por: Li, Shuting, et al.
Publicado: (2017)

Reprogramming of the Tumor Microenvironment by Stromal Pten-regulated miR-320
por: Bronisz, A, et al.
Publicado: (2011)

SQLE Mediates Metabolic Reprogramming to Promote LN Metastasis in Castration-Resistant Prostate Cancer
por: Xu, Zhenzhou, et al.
Publicado: (2021)

Metabolic Reprogramming in COVID-19
por: Shen, Tao, et al.
Publicado: (2021)

Comprehensive Analysis of the Relationship Between Metabolic Reprogramming and Immune Function in Prostate Cancer
por: Xie, Weijie, et al.
Publicado: (2021)

The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
por: Turnham, Daniel J., et al.
Publicado: (2020)

Bladder Cancer‐Derived Small Extracellular Vesicles Promote Tumor Angiogenesis by Inducing HBP‐Related Metabolic Reprogramming and SerRS O‐GlcNAcylation in Endothelial Cells
por: Li, Xinyuan, et al.
Publicado: (2022)

Metabolic Reprogramming by Malat1 Depletion in Prostate Cancer
por: Nanni, Simona, et al.
Publicado: (2020)

Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
por: Li, Xiaoran, et al.
Publicado: (2017)

SOX2 Mediates Metabolic Reprogramming of Prostate Cancer Cells
por: de Wet, Larischa, et al.
Publicado: (2022)

Exploiting the Metabolic Consequences of PTEN Loss and Akt/Hexokinase 2 Hyperactivation in Prostate Cancer: A New Role for δ-Tocotrienol
por: Fontana, Fabrizio, et al.
Publicado: (2022)

β-Catenin Is Required for Prostate Development and Cooperates with Pten Loss to Drive Invasive Carcinoma
por: Francis, Jeffrey C., et al.
Publicado: (2013)

Genomic Deletion at 10q23 in Prostate Cancer: More Than PTEN Loss?
por: Poluri, Raghavendra Tejo Karthik, et al.
Publicado: (2018)

PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles
por: Geybels, Milan S., et al.
Publicado: (2017)

V-ATPase-associated prorenin receptor is upregulated in prostate cancer after PTEN loss
por: Mohammad, Amro H., et al.
Publicado: (2019)

TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN-loss
por: Pietrzak, Karolina, et al.
Publicado: (2020)

Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss
por: Bastos, Débora C, et al.
Publicado: (2020)

Cytoplasmic PTEN Protein Loss Distinguishes Intraductal Carcinoma of the Prostate from High Grade Prostatic Intraepithelial Neoplasia
por: Lotan, Tamara L., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c9qb9fbtrjskg5j2nff9f9t0vk